Among the 2,105 Enterobacteriaceae tested in a survey done in Portugal, 165 were nonsusceptible to carbapenems, from which 35 (26 Klebsiella pneumoniae, 3 Escherichia coli, 2 Enterobacter aerogenes, and 3 Enterobacter cloacae isolates and 1 Klebsiella oxytoca isolate) were confirmed to be carbapenemase producers by the presence of 30 Tn4401d-bla KPC-3 , 4 intI3-bla GES-5 , and one intI1-bla VIM-2 gene, alone or in combination with other bla genes. The dissemination of bla KPC-3 gene carried by an IncF plasmid suggests lateral gene transfer as a major mechanism of dissemination.
C
arbapenem-nonsusceptible Enterobacteriaceae are increasingly reported worldwide, mainly because of the acquisition of carbapenemase-encoding genes located on highly mobile genetic elements (e.g., plasmids and/or integrons) that facilitate their horizontal spread (1, 2) . In Portugal, little is known regarding the molecular epidemiology of carbapenemase-producing Enterobacteriaceae (CPE). Indeed, only sporadic isolates or single hospital cases have been described (3), namely, a VIM-2-producing Klebsiella oxytoca isolate (4), 2 VIM-34-producing Klebsiella pneumoniae isolates (5), and 6 K. pneumoniae carbapenemase (KPC)-3-producing Enterobacteriaceae isolates (6) . The objectives of this study were to (i) characterize a large number of CPE isolates recovered from different Portuguese health care institutions, (ii) determine the potential diversity of these isolates, and (iii) describe the respective plasmids harboring carbapenemase-encoding genes in an international context. This study included 2,105 consecutive and nonrepetitive clinical Enterobacteriaceae isolates that were collected between April 2006 and February 2013 and sent to the National Reference Laboratory of Antimicrobial Resistances at the National Institute of Health, as an integrative part of the Antimicrobial Resistance Surveillance Program in Portugal (ARSIP) laboratory. ARSIP is a voluntary Portuguese surveillance program that continually monitors the susceptibilities of pathogens of clinical importance against several antibiotics. Thirteen Portuguese hospitals located in five different regions (North, Central, Lisbon and Tagus Valley, South, and Autonomous Region of Madeira) participated in this survey.
The screening of carbapenem susceptibility, performed by the disk diffusion method, according to the French Society for Microbiology (http://www.sfm-microbiologie.org/), revealed that 165 (7.8%) isolates were ertapenem-nonsusceptible, and these were selected for further analysis. In addition, clinical isolates showing an inhibition of carbapenemase, as evidenced by the synergy between carbapenems (imipenem, meropenem, and/or ertapenem) and 3-aminophenylboronic acid or EDTA, were considered presumptive carbapenemase producers from class A or B, respectively (7) .
Thirty-five isolates suspected to produce CPE (35/168 [20.8%] ) demonstrated a positive synergy between carbapenems and 3-aminophenylboronic acid (n ϭ 34) or with EDTA (n ϭ 1), indicative of serine or metallo-␤-lactamase production, respectively. The majority of those isolates were collected from urine samples (54.3%) from elderly (Ն65 years old) male patients (54.3%), admitted to the emergency room/ambulatory (22.9%), internal medicine (17.1%), or surgery (17.1%) wards. The diminished susceptibilities to carbapenems among the remaining 130 ertapenem-nonsusceptible isolates (59 Klebsiella spp., 28 Enterobacter spp., 23 Escherichia coli, 11 Morganella morganii, 8 Proteus mirabilis, and 1 Serratia marcescens) suggested a decrease in the outer membrane permeability associated with the weak hydrolytic activity of carbapenems due to the expression of a ␤-lactamase, such as extended-spectrum ␤-lactamases (ESBLs), and/or AmpC overexpression (7) .
The MICs of the 35/168 isolates were obtained by the reference microdilution broth method (8, 9) , according to the EUCAST guidelines (http://www.eucast.org/clinical_breakpoints/). Tigecycline and ciprofloxacin were potent against 57.1% and 28.6% of the isolates, respectively, but colistin was the only antibiotic effective against all CPE isolates; all isolates were multidrug resistant (MDR), i.e., presented reduced susceptibility to three or more structurally unrelated antibiotics (10) ( Table 1) .
PCR amplification and DNA sequencing were applied to the 165 ertapenem-nonsusceptible isolates to identify the presence or confirm the absence of the carbapenemase-encoding genes bla KPC and bla GES (class A), bla IMP , bla VIM , and bla NDM (class B), and bla OXA-48 (class D) (11) . Among the 165 isolates, only the 35 identified as carbapenemase-producing isolates were confirmed to be An analysis of the genetic elements associated with the CPEencoding genes showed that all the bla KPC-3 genes were flanked by ISKpn7 on the right and ISKpn6 on the left (12) and a Tn3-like Tn4401 transposon, with a 68-bp deletion upstream of bla KPC-3 , corresponding to the isoform d. This uncommon isoform has been described so far only in KPC-producing K. pneumoniae strains with high-level carbapenem resistance in the United States and Canada (13) (14) (15) .
Regarding the bla GES-5 genes, the PCR results and sequence analysis, using previously described primers (11) , revealed the amplification of the intI3-bla GES-5 region, where the intI3 gene was located adjacent to the bla GES-5 gene in a configuration previously reported for the bla GES-1 gene (16, 17) . intI3 was targeted and amplified with a set of primer pairs (5=-GCAAGTGGGTGGCGA ATG-3= and 5=-CTGAAGTCGAGGGTTTTCTG-3=) designed in this study (with initial denaturation at 94°C for 5 min, 30 cycles of denaturation at 94°C for 30 s, annealing at 58°C for 60 s, and extension at 72°C for 60 s, and a final extension at 72°C for 5 min). This study represents one of the very few reports of the acquisition of carbapenemase-encoding genes mediated by a class 3 integron (18, 19) , and to our knowledge, those are the first such genes to have been found in CPE isolates. Notable is the fact that two isolates (Kp17060 and Kp17061, Table 1 ) were collected on the same day from patients admitted in the same hospital room, suggesting that organisms were transferred through direct contact. Also, we confirmed the location of the bla VIM-2 gene in a class 1 integron, as previously described (4) .
In our study, among the 15 isolates with CPE-encoding genes randomly selected to be tested for transferability by broth mating-out assays using recipient rifampin-resistant (Rif r ) or streptomycin-resistant (Str r ) E. coli C600 and sodium azide-resistant (NaN 3 r ) E. coli J53 strains (11), we obtained 10 (66.7%) transconjugants with bla KPC-3 -harboring plasmids. Using PCRbased replicon typing to type the resistance plasmids (20), we observed the transfer of an IncF group harboring the bla KPC-3 and bla TEM-1 genes within the recipient NaN3 r E. coli J53 (n ϭ 9) and Rif r E. coli C600 (n ϭ 1) strains. The location of the bla KPC gene has been observed in plasmids of various sizes, belonging to the IncF, IncL/M, and IncN plasmid types, and also on small rolling circlereplicating (RCR) plasmids that are not self-transmissible but can mobilized in trans by coresident conjugative plasmids (2) . In this study, we identified the IncF plasmid in different species, such as Klebsiella spp. and Enterobacter spp., suggesting that the dissemination of the bla KPC-3 gene is due to lateral gene transfer rather than clonal spread. In general, the MICs of the transconjugants showed similar susceptibility profiles as those of the donor strains with nonsusceptibility to meropenem, ertapenem, cefotaxime, ceftazidime, gentamicin, and trimethoprim, as well as those with susceptibility to colistin and tigecycline. Regarding imipenem (n ϭ 7), doripenem (n ϭ 9), and ciprofloxacin (n ϭ 9), the majority of the transconjugants were susceptible in comparison to the clinical isolates, with MICs from 8 mg/liter to 1 mg/liter for imipenem, 2 mg/liter to 0.25 mg/liter for doripenem, and 0.125 mg/liter to Յ0.06 mg/liter for ciprofloxacin.
Multilocus sequence typing of K. pneumoniae (n ϭ 26) isolates (http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html) showed a high degree of genetic diversity, as they were from distinct sequence types (STs), namely, ST14, ST15, ST34, ST59, ST147, ST416, and ST698, and from the two novel STs ST960 and ST1138 (Table 2) . Overall, 10 STs were observed to be associated with KPC production, with ST147 (n ϭ 4), ST1138 (n ϭ 4), and ST15 (n ϭ (22) ST11 ( 4) being the most prevalent types. ST147 is an important clone associated with this resistance mechanism worldwide, namely due to VIM-, KPC-, and NDM-producing K. pneumoniae isolates (21, 22) , while ST1138 was first described here in 4 KPC-3-producing K. pneumoniae isolates coexpressing TEM-1 and SHV-36 (Table  2) . Interestingly, isolates belonging to the well-known lineage of K. pneumoniae ST258, which plays a major role in the global spread of KPC carbapenemases (23), were not found. Regarding KPC-producing E. coli (n ϭ 3) (http://mlst.warwick.ac.uk/mlst /dbs/Ecoli), all isolates belonged to ST58.
In conclusion, this study provides new data regarding the molecular epidemiology of CPE in Portugal, with the emergence of the carbapenemase KPC-3. Indeed, this study suggests that the dissemination of the bla KPC-3 gene occurs due to the dispersion of Tn4401d, carried by an IncF plasmid and spread both by polyclonal K. pneumoniae and by Enterobacter aerogenes, Enterobacter cloacae, and E. coli clinical strains.
